Homology Medicines
Founded
2015
2015
Geography
United States of America based
United States of America based
Funding
$127 M
$127 M
Homology Medicines is a genetic medicines company translating proprietary, cutting-edge gene editing and gene therapy technology into cures for patients with rare diseases. It is taking a slightly different tack from other players in the gene-editing domain with its adeno-associated virus (AAV) technology AMEnDR. It’s a different approach to other techniques such as CRISPR/cas9 or zinc finger nucleases
Technologies
Gene Therapy StartupsR&D Platform
Pipelines
No pipelines published yet
Products
Services
No services posted yet